Perindopril Alters Vascular Angiotensin-Converting Enzyme, AT1 Receptor, and Nitric Oxide Synthase Expression in Patients With Coronary Heart Disease

No abstract is available for this paper.

• Publication year

  2002

• Venue

  HYPERTENSION

• Publication date

  2002-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/HY0202.103417PMID 11882622
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparative Effect of ACE Inhibition and Angiotensin II Type 1 Receptor Antagonism on Bioavailability of Nitric Oxide in Patients With Coronary Artery Disease: Role of Superoxide Dismutase

  2001cited by this paper
• Increased Angiotensin-Converting Enzyme Activity in Coronary Artery Specimens From Patients With Acute Coronary Syndrome

  2001cited by this paper
• Combined Angiotensin II Receptor Antagonism and Angiotensin-Converting Enzyme Inhibition Further Attenuates Postinfarction Left Ventricular Remodeling

  2001cited by this paper
• Increased angiotensin‐converting enzyme and type 1 angiotensin receptors in cortical vasculature and tubulointerstitium of chronically rejected human kidney allografts

  2001cited by this paper
• Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study)

  2000cited by this paper
• Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

  2000cited by this paper
• Angiotensin II receptor blockers: equal or preferred substitutes for ACE inhibitors?

  2000cited by this paper
• Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

  2000cited by this paper
• Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.

  2000cited by this paper
• Roles of AT1 and AT2 receptors in the hypertensive Ren-2 gene transgenic rat kidney.

  1999cited by this paper
• Relative localization of angiotensin-converting enzyme, chymase and angiotensin II in human coronary atherosclerotic lesions.

  1999cited by this paper
• Perindopril chronically inhibits angiotensin-converting enzyme in both the endothelium and adventitia of the internal mammary artery in patients with ischemic heart disease.

  1997cited by this paper
• Nitric Oxide in the Vasculature: Physiology and Pathophysiology

  1997cited by this paper
• Upregulation of angiotensin-converting enzyme during the healing process after injury at the site of percutaneous transluminal coronary angioplasty in humans.

  1997cited by this paper
• Recognition of tissue- and subtype-specific modulation of angiotensin II receptors using antibodies against AT1 and AT2 receptors.

  1997cited by this paper
• Acute and chronic in vivo inhibition of angiotensin-converting enzyme by perindopril in the endothelium and adventitia of large arteries and organs of the rabbit.

  1997cited by this paper
• Angiotensin II receptors and angiotensin II receptor antagonists.

  1993cited by this paper
• Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response?

  1992cited by this paper
• Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions.

  1992cited by this paper
• Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

  1992cited by this paper
• Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction

  1992cited by this paper
• Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

  1991cited by this paper
• Immunohistologic characterization of angiotensin converting enzyme in the human kidney using monoclonal and polyclonal antibodies.

  1989cited by this paper

• Perindopril: A comprehensive profile.

  2026cites this paper
• Modern antihypertensive therapy: the effectiveness of a unique Russian fixed-dose combination of ramipril and indapamide

  2020cites this paper
• NOS+SARS-CoV-2 Pathogenesis

  2020cites this paper
• Exploring the binding interaction between bovine serum albumin and perindopril as well as influence of metal ions using multi-spectroscopic, molecular docking and DFT calculation

  2020cites this paper
• Histopathological and proteomic analyses identify integrin-β1 as a potential mediator of phlebosclerosis in uremic patients

  2019cites this paper
• A phase II trial of the effect of perindopril on hand–foot skin reaction (HFSR) incidence and severity in patients receiving regorafenib for refractory mCRC

  2018cites this paper
• TAK-272 (imarikiren), a novel renin inhibitor, improves cardiac remodeling and mortality in a murine heart failure model

  2018cites this paper
• Drainage versus defense: The management of vascular leakage in cardiovascular diseases

  2018influential citation
• Allopurinol, benzbromarone and risk of coronary heart disease in gout patients: A population-based study.

  2017cites this paper
• Blood pressure normalization via pharmacotherapy improves cutaneous microvascular function through NO‐dependent and NO‐independent mechanisms

  2017cites this paper
• ANALYTICAL METHODS OF PERINDOPRIL, REVIEW

  2017cites this paper
• Functional and Biochemical Endothelial Profiling In Vivo in a Murine Model of Endothelial Dysfunction; Comparison of Effects of 1-Methylnicotinamide and Angiotensin-converting Enzyme Inhibitor

  2017cites this paper
• Angiotensin II AT1 receptor alters ACE2 activity, eNOS expression and CD44-hyaluronan interaction in rats with hypertension and myocardial fibrosis.

  2016cites this paper
• Running Head: Angiotensin-(1–7) mitigates right ventricular fibrosis

  2015cites this paper
• The Renin-Angiotensin System and the Kidney: New Insights and Perspectives

  2015cites this paper
• CALL FOR PAPERS Cardiovascular Consequences of Obesity and Type 2 Diabetes Angiotensin-(1–7) treatment mitigates right ventricular fibrosis as a distinctive feature of diabetic cardiomyopathy

  2015cites this paper
• Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients

  2014cites this paper
• Perindopril vs Enalapril in Patients with Systolic Heart Failure: Systematic Review and Metaanalysis.

  2014cites this paper
• Endothelial nitric oxide synthase gene polymorphisms and renal responsiveness to RAS inhibition therapy in type 2 diabetic Asian Indians.

  2013cites this paper
• Not All Angiotensin-Converting Enzyme Inhibitors Are Equal: Focus on Ramipril and Perindopril

  2013cites this paper
• Propofol Increases Vascular Relaxation in Aging Rats Chronically Treated with the Angiotensin-Converting Enzyme Inhibitor Captopril

  2013cites this paper
• Angiotensin Antagonism in Coronary Artery Disease

  2012influential citation
• Perindopril

  2012cites this paper
• Perindopril

  2012cites this paper
• Relationship between angiotensin II receptor expression and cardiovascular risk factors in Mexican patients with coronary occlusive disease.

  2011cites this paper
• Implicações farmacogenéticas de polimorfismos da eNOS para drogas de ação cardiovascular

  2011cites this paper
• Pharmacogenetic implications of the eNOS polymorphisms for cardiovascular action drugs.

  2011cites this paper
• The effects of perindopril on QT duration and dispersion in patients with coronary slow flow

  2011cites this paper
• Perindopril for the treatment of hypertension

  2011cites this paper
• Coronary Atherosclerotic Plaques Cellular Immunostaining of Angiotensin-Converting Enzyme in Human

  2011cites this paper
• Dose-Dependent Antihypertensive Efficacy and Tolerability of Perindopril in a Large, Observational, 12-Week, General Practice-Based Study

  2011cites this paper
• Oxidants and Endothelial Dysfunction

  2010cites this paper
• Клиническая эффективность периндоприла аргинина (Престариум А) у пациентов с артериальной гипертензией и гипертрофией левого желудочка

  2010cites this paper
• Eine pharmakologische Stimulierung der endothelialen NO-Synthase führt zu einer Verbesserung der diastolischen Dysfunktion im hypertensiven Dahl-Salz Rattenmodell

  2010cites this paper
• Regulation of Kinin Receptor Expression in Heart Failure with a Focus on Vascular Endothelium

  2010cites this paper
• Hydrophilic interaction liquid chromatography/positive ion electrospray ionization mass spectrometry method for the quantification of perindopril and its main metabolite in human plasma

  2010cites this paper
• Inhibition of angiotensin‐converting enzyme stimulates fracture healing and periosteal callus formation – role of a local renin‐angiotensin system

  2010cites this paper
• Antihypertensive Efficacy of Perindopril 5–10 mg/day in Primary Health Care

  2009cites this paper
• Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease

  2009cites this paper
• Secondary Prevention of Coronary Disease with ACE Inhibition-does Blood Pressure Reduction with Perindopril Explain the Benefits in EUROPA?

  2009influential citation
• Telmisartan predominantly suppresses cardiac fibrosis, rather than hypertrophy, in renovascular hypertensive rats

  2009cites this paper
• Angiotensin-converting enzyme inhibitors and atherosclerotic plaque: a key role in the cardiovascular protection of patients with coronary artery disease

  2009cites this paper
• Quinaprilat-eluting stents do not attenuate intimal thickening following stenting in porcine coronary arteries.

  2009cites this paper
• Impact of the therapy by renin–angiotensin system targeting antihypertensive agents perindopril versus telmisartan on prothrombotic state in essential hypertension

  2008cites this paper
• Angiotensin Converting Enzyme Inhibition Enhances Collateral Artery Remodeling in Rats With Femoral Artery Occlusion

  2008cites this paper
• ADDITIONAL EFFECT IN REDUCTION OF ALBUMINURIA DUE TO THE COMBINATION THERAPY OF ANGIOTENSIN-CONVERTING­ ENZYME INHIBITORAND ANGIOTENSIN IT TYPE 1 RECEPTOR BLOCKER IN TYPE 2 DIABETIC PATIENTS WITH THE ANGIOTENSINOGEN 235T ALLELE

  2008cites this paper
• Beneficial effect of perindopril on cardiac sympathetic nerve activity and brain natriuretic peptide in patients with chronic heart failure: comparison with enalapril.

  2008cites this paper
• Review: Angiotensin-converting enzyme inhibitors and coronary heart disease prevention

  2007cites this paper
• Cardiovascular Disease and Insulin Resistance

  2007cites this paper
• Secondary Prevention of Coronary Artery Disease and the Choice of the ACE Inhibitor Why EUROPA and not PEACE

  2007cites this paper
• ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT.

  2007cites this paper
• Chapter 14 – The Endothelium in Hypertension: Assessment and Clinical Aspects of Micro- and Macrovascular Function

  2007cites this paper
• ACE Inhibition and Endothelial Function: Main Findings of PERFECT, a Sub-Study of the EUROPA Trial

  2007cites this paper
• Perindopril: the evidence of its therapeutic impact in hypertension

  2007cites this paper
• Perindopril versus Angiotensin II Receptor Blockade in Hypertension and Coronary Artery Disease

  2007cites this paper
• Angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors: where do we stand now?

  2007cites this paper
• ACE Inhibition in Hypertension

  2007cites this paper
• Therapeutic modulation of the nitric oxide: all ace inhibitors are not equivalent.

  2007cites this paper
• The endothelial nitric oxide synthase gene -786T/C polymorphism is a predictive factor for reattacks of coronary spasm

  2007cites this paper
• Characterization and localization of Ac-SDKP receptor binding sites using 125I-labeled Hpp-Aca-SDKP in rat cardiac fibroblasts.

  2007cites this paper
• Cellular immunostaining of angiotensin-converting enzyme in human coronary atherosclerotic plaques.

  2006cites this paper
• EFFECTS OF PERINDOPRIL AND HYDROCHLOROTHIAZIDE ON SELECTED INDICES OF OXIDATIVE STRESS IN THE BLOOD OF ELDERLY PATIENTS WITH ESSENTIAL HYPERTENSION

  2006cites this paper
• Nitric oxide signaling in the cardiovascular system: implications for heart failure

  2006cites this paper
• Coagulation and atherothrombotic disease.

  2006cites this paper
• Endothelial Protection, AT1 Blockade and Cholesterol-Dependent Oxidative Stress: The EPAS Trial

  2006cites this paper
• Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.

  2006cites this paper
• Quinapril treatment increases insulin-stimulated endothelial function and adiponectin gene expression in patients with type 2 diabetes.

  2006cites this paper
• [Scientific value of the EUROPA Study: mechanisms of beneficial effect of perindopril in atherosclerosis].

  2005cites this paper
• Captopril Restores Endothelium-Dependent Relaxation Induced by Advanced Oxidation Protein Products in Rat Aorta

  2005cites this paper
• Angiotensin Type 2 Receptor Is Expressed in Murine Atherosclerotic Lesions and Modulates Lesion Evolution

  2005cites this paper
• Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril

  2005cites this paper
• Effects of cilazapril on endothelial cell function and fibrinolysis system in atrial fibrillation.

  2005cites this paper
• Platelet aggregation and vasoconstriction related to platelet cyclooxygenase and 12-lipoxygenase pathways.

  2005cites this paper
• Angiotensin antagonism in coronary artery disease: results after coronary revascularisation.

  2005cites this paper
• The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudy.

  2005cites this paper
• [Nitric oxide: physiological and pathophysiological properties].

  2005cites this paper
• Combination of half doses of angiotensin type 1 receptor antagonist and angiotensin-converting enzyme inhibitor in diabetic nephropathy.

  2005cites this paper
• Specific properties and effect of perindopril in controlling the renin-angiotensin system.

  2005cites this paper
• Perindopril: the reasonable choice in patients with coronary artery disease

  2005cites this paper
• Provision of cardiovascular protection by ACE inhibitors:a review of recent trials

  2004cites this paper
• Skuteczność i tolerancja perindoprilu w leczeniu pierwotnego nadciśnienia tętniczego u kobiet po menopauzie Efficacy and tolerability of perindopril in the treatment of essential hypertension in postmenopausal women

  2004cites this paper
• Pharmakologische Grundlagen der medikamentsen antihypertensiven Therapie

  2004cites this paper
• Effects of perindopril treatment on hemostatic function in patients with essential hypertension in relation to angiotensin converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms.

  2004cites this paper
• Endothelial dysfunction in heart failure: mechanisms and therapeutic approaches.

  2004cites this paper
• [Ischemic heart disease with low risk of vascular complications -- a novel indication for angiotensin converting enzyme inhibitors (results of EUROPA trial)].

  2004cites this paper
• Preserving bradykinin or blocking angiotensin II: the cardiovascular dilemma

  2004cites this paper
• Angiotensin II, PPAR-gamma and atherosclerosis.

  2004cites this paper
• AT1 and AT2-Receptor Antagonists Inhibit Ang II-Mediated Facilitation of Noradrenaline Release in Human Atria

  2004cites this paper
• Antihypertensive therapy and endothelial function.

  2004cites this paper
• Endothelial dysfunction in congestive heart failure: ACE inhibition vs. angiotensin II antagonism

  2004cites this paper
• Cardioprotective Action of Perindopril versus Candesartan in Renovascular Hypertensive Rats

  2004influential citation
• Angiotensin II Differentially Regulates Interleukin-1-β-inducible NO Synthase (iNOS) and Vascular Cell Adhesion Molecule-1 (VCAM-1) Expression

  2004cites this paper
• Angiotensin-converting enzyme inhibition and angiogenesis in myocardium of obese Zucker rats.

  2004cites this paper
• Poststroke patients: implications for the cardiologist

  2004cites this paper
• Addition of the selective aldosterone receptor antagonist eplerenone to ACE inhibition in heart failure: effect on endothelial dysfunction.

  2003cites this paper
• Normalization of Endothelial and Inducible Nitric Oxide Synthase Expression in Brain Microvessels of Spontaneously Hypertensive Rats by Angiotensin II AT1 Receptor Inhibition

  2003cites this paper
• Effects of low-dose combination therapy with an angiotensin-converting enzyme inhibitor and a diuretic on flow-mediated vasodilation in hypertensive patients: a 6-month, single-center study.

  2003cites this paper
• Treatment of hypertensive patients with coexisting coronary arterial disease

  2003cites this paper
• Can Angiotensin-converting Enzyme Inhibitors Reverse Atherosclerosis?

  2003cites this paper
• The prothrombotic state in hypertension and the effects of antihypertensive treatment.

  2003cites this paper